News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Myriad Genetics, Inc. (MYGN) Partners With Mammography Reporting System, Inc. to Increase Identification of High Risk Breast Cancer Patients


1/7/2010 9:18:27 AM

SALT LAKE CITY, Jan. 6, 2010 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) announced today it has entered into an agreement with Mammography Reporting System, Inc. (MRS) to help increase the identification of patients at high risk for hereditary breast cancer.

Read at GlobeNewswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES